JP2012201599A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012201599A5 JP2012201599A5 JP2011064911A JP2011064911A JP2012201599A5 JP 2012201599 A5 JP2012201599 A5 JP 2012201599A5 JP 2011064911 A JP2011064911 A JP 2011064911A JP 2011064911 A JP2011064911 A JP 2011064911A JP 2012201599 A5 JP2012201599 A5 JP 2012201599A5
- Authority
- JP
- Japan
- Prior art keywords
- propionic acid
- blood cholesterol
- cholesterol
- reducing agent
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 20
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 16
- 210000004369 blood Anatomy 0.000 claims 11
- 239000008280 blood Substances 0.000 claims 11
- 241000894006 Bacteria Species 0.000 claims 8
- 235000019260 propionic acid Nutrition 0.000 claims 8
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 8
- 239000003638 chemical reducing agent Substances 0.000 claims 7
- 235000013305 food Nutrition 0.000 claims 4
- 241000186426 Acidipropionibacterium acidipropionici Species 0.000 claims 2
- 241000186425 Acidipropionibacterium jensenii Species 0.000 claims 2
- 241000186428 Propionibacterium freudenreichii Species 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 238000008214 LDL Cholesterol Methods 0.000 claims 1
- 108010028554 LDL Cholesterol Proteins 0.000 claims 1
- 108010069201 VLDL Cholesterol Proteins 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000012752 auxiliary agent Substances 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011064911A JP5818309B2 (ja) | 2011-03-23 | 2011-03-23 | 血中コレステロール低減剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011064911A JP5818309B2 (ja) | 2011-03-23 | 2011-03-23 | 血中コレステロール低減剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012201599A JP2012201599A (ja) | 2012-10-22 |
| JP2012201599A5 true JP2012201599A5 (enExample) | 2014-04-03 |
| JP5818309B2 JP5818309B2 (ja) | 2015-11-18 |
Family
ID=47182952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011064911A Active JP5818309B2 (ja) | 2011-03-23 | 2011-03-23 | 血中コレステロール低減剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5818309B2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102017105036A1 (de) * | 2017-03-09 | 2018-09-13 | Flexopharm Brain Gmbh & Co. Kg | Mittel zur Anwendung bei der Behandlung der Dyslipidämie |
| KR102154124B1 (ko) * | 2019-06-14 | 2020-09-09 | 고려대학교 산학협력단 | 프로피오니박테리움 프레우덴레키 mj2 균주를 유효성분으로 포함하는 대사성 질환 및 비만 관련 대사 이상의 예방, 치료, 또는 개선용 조성물 |
| JP7402628B2 (ja) | 2019-07-19 | 2023-12-21 | 株式会社明治 | 組成物 |
| JP7402629B2 (ja) * | 2019-07-19 | 2023-12-21 | 国立大学法人東京農工大学 | プロピオン酸菌発酵物含有組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ537242A (en) * | 2002-06-21 | 2008-10-31 | Newcastle Innovation Ltd | Probiotic propionibacterium jensenii 702 |
| US20100247500A1 (en) * | 2007-11-27 | 2010-09-30 | Kakuhei Isawa | Agent and method for improving survivability of lactic acid bacterium, and food composition |
-
2011
- 2011-03-23 JP JP2011064911A patent/JP5818309B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ng et al. | Evaluation of probiotic potential of lactic acid bacteria isolated from traditional Malaysian fermented Bambangan (Mangifera pajang) | |
| JP7387587B2 (ja) | クロストリジウム・ディフィシル感染症の治療における新たな使用 | |
| RU2664479C2 (ru) | Композиции и способы | |
| Ooi et al. | Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings | |
| CN105979952B (zh) | 协同细菌组合物以及其制造方法和用途 | |
| JP2016537410A5 (enExample) | ||
| US20180078588A1 (en) | Compositions and methods for treatment of skin disorders | |
| Watanabe et al. | Prebiotic properties of epilactose | |
| WO2012091081A8 (ja) | 乳酸菌を含むインターフェロン産生誘導剤 | |
| FR2999601A1 (fr) | Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis | |
| WO2009013709A3 (en) | Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same | |
| WO2009043856A3 (en) | Modulation of tissue fatty acid composition of a host by human gut bacteria | |
| JP2012201599A5 (enExample) | ||
| WO2009066537A1 (ja) | 免疫調節性機能誘導剤及び食品組成物 | |
| JP2012057170A5 (enExample) | ||
| JP2015525572A5 (enExample) | ||
| JP2011504366A5 (enExample) | ||
| Del Piano et al. | Assessment of the capability of a gelling complex made of tara gum and the exopolysaccharides produced by the microorganism Streptococcus thermophilus ST10 to prospectively restore the gut physiological barrier: a pilot study | |
| JP2008538288A5 (enExample) | ||
| Lindström et al. | Oral administration of live exopolysaccharide-producing Pediococcus parvulus, but not purified exopolysaccharide, suppressed Enterobacteriaceae without affecting bacterial diversity in ceca of mice | |
| Lebeer et al. | Topical cream with live lactobacilli modulates the skin microbiome and reduce acne symptoms | |
| RU2012134407A (ru) | Способ приготовления биомассы, содержащей плантарицин, и ее применение в медицинских целях | |
| Sun et al. | The anti-inflammatory potential of a strain of probiotic Bifidobacterium pseudocatenulatum G7: in vitro and in vivo evidence | |
| JP2009232702A5 (enExample) | ||
| Awasthi et al. | Gut dysbiosis and diabetic foot ulcer: role of probiotics |